Steroid-resistant acute rejection after liver transplantation
10.3760/cma.j.issn.1007-631X.2009.11.010
- VernacularTitle:肝移植术后耐激素冲击治疗的急性排斥反应的诊治
- Author:
Linwei WU
;
Xiaoshun HE
;
Weiqiang JU
;
Xiaofeng ZHU
;
Yi MA
;
Dongping WANG
;
Qiang TAI
;
Anbin HU
;
Guodong WANG
- Publication Type:Journal Article
- Keywords:
Liver transplantation;
Hormones;
Graft rejection
- From:
Chinese Journal of General Surgery
2009;24(11):892-894
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the outcome and treatment for recipients with steroid-resistant acute rejection (SRAR) after liver transplantation. Methods From Jan 2004 to Dec 2007, 596 adult patients received liver transplantation in the Organ Transplantation Center, the First Affiliated Hospital of Sun Yat-Sen University,96 recipients experienced 113 episodes of acute rejection (AR)after the operation, 11 recipients had no response to conventional steroid bolus treatment, the clinical data of this group of patients was analyzed retrospectively. Results Incidence rate of AR in our single center was 16.1% (96/596), among them 9.7% (11/113) were steroid-resistant. SRAR occurred averagely on 19 d (6-72 d)after liver transplantation, 3 were controlled by OKT3 treatment, 4 were reversed by IL-2 receptor inhibitors combined with MMF. Rejection could not be reversed in 4 patients and 2 finally received retransplantation. Mortality rate associated with SRAR was 36.4% (4/11) including, one from acute liver failure, 1 from chronic liver failure, 1 from renal failure after retransplantation and 1 from pulmonary infection after OKT3 treatment. Conclusion SRAR is a severe complication with high mortality after liver transplantation, OKT3 and IL-2 receptor inhibitors are effective in only a portion of these patients.
